AG120, a first-in-class mutant IDH1 inhibitor in patients with recurrent or progressive IDH1 mutant glioma: Results from the phase 1 glioma expansion cohorts Meeting Abstract

  

Authors:	Mellinghoff, I. K.; Touat, M.; Maher, E.; DeLaFuente, M.; Cloughesy, T. F.; Holdhoff, M.; Cote, G.; Burris, H.; Janku, F.; Huang, R.; Young, R.; Ellingson, B.; Auer, J.; Liu, H.; Hurov, J.; Yen, K.; Agresta, S.; Attar, E.; Pandya, S.; Wen, P. Y.
Abstract Title:	AG120, a first-in-class mutant IDH1 inhibitor in patients with recurrent or progressive IDH1 mutant glioma: Results from the phase 1 glioma expansion cohorts
Meeting Title:	21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	18
Issue:	Suppl. 6
Meeting Dates:	2016 Nov 17-20
Meeting Location:	Scottsdale, AZ
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2016-11-01
Start Page:	vi12
Language:	English
ACCESSION:	WOS:000398604100046
PROVIDER:	wos
DOI:	10.1093/neuonc/now212.044
Notes:	Meeting Abstract: ACTR-46 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/111000